TD AMERITRADE INVESTMENT MANAGEMENT, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 5 filers reported holding SEATTLE GENETICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TD AMERITRADE INVESTMENT MANAGEMENT, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2021$239,0000.0%1,2230.0%0.00%0.0%
Q3 2020$239,000
+26.5%
1,223
+10.1%
0.00%0.0%
Q2 2020$189,000
+57.5%
1,111
+7.0%
0.00%
+100.0%
Q1 2020$120,000
+3.4%
1,038
+2.1%
0.00%0.0%
Q4 2019$116,000
+127.5%
1,017
+70.1%
0.00%
Q3 2019$51,000
+466.7%
598
+367.2%
0.00%
Q2 2019$9,0001280.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 44,100,294$2,381,857,00021.61%
Lagoda Investment Management, L.P. 567,057$30,627,0009.21%
Redmile Group, LLC 1,781,470$96,217,0007.65%
Boxer Capital, LLC 232,600$12,563,0005.63%
NEXTHERA CAPITAL LP 111,500$6,022,0003.70%
Eventide Asset Management 835,506$45,126,0002.76%
WASATCH ADVISORS LP 2,844,908$153,653,0002.29%
Opus Point Partners Management, LLC 67,953$3,670,0002.06%
CORRADO ADVISORS, LLC 43,050$2,325,0001.48%
Baillie Gifford 16,795,793$907,142,0001.42%
View complete list of SEATTLE GENETICS INC shareholders